Disclosed is a contrast medium for thrombus which comprises, as an active substance, a substance obtained by labeling a compound capable of binding to glycoprotein IIb/IIIa or a physiologically acceptable salt thereof with a positron emitting isotope 11C, the compound being represented by the general formula (IV):wherein R9 represents a hydrogen atom or an amino protective group.
